Prosecution Insights
Last updated: April 19, 2026

Arena Pharmaceuticals, Inc.

8 pending office actions

Portfolio Summary

8
Total Pending OAs
0
Final Rejections
8
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18566862 Administration of a Compound to Individuals with Hepatic Impairment TRAN, ERIC 1629 Non-Final OA Dec 04, 2023
18565626 METHODS OF TREATMENT VALENROD, YEVGENY 1628 Non-Final OA Nov 30, 2023
18524124 METHODS OF TREAMENT INAM, SAHAR 1622 Non-Final OA Nov 30, 2023
18548622 Methods of Treatment with Selective CB2 Receptor Agonists BELL, SARA ELIZABETH 1625 Non-Final OA Sep 01, 2023
18250596 METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR JEAN-LOUIS, SAMIRA JM 1642 Non-Final OA Apr 26, 2023
18249774 ISOXAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERED RELATED THERETO BRAUN, MADELINE E 1624 Non-Final OA Apr 20, 2023
18079941 DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO HAVLIN, ROBERT H 1626 Non-Final OA Dec 13, 2022
17990068 COMPOUNDS AND METHODS FOR TREATMENT OF PRIMARY BILIARY CHOLANGITIS PIHONAK, SARAH 1627 Non-Final OA Nov 18, 2022

Managing Arena Pharmaceuticals, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month